Robuta

https://themedtechdigest.com/kurt-gielen-managing-director-of-medace-why-u-s-medtech-leaders-cant-ignore-europes-medtech-shake-up/ Kurt Gielen, Managing Director of Medace: Why U.S. MedTech Leaders Can’t Ignore Europe’s... Sep 15, 2025 - Why Europe’s shifting regulatory landscape, global trade tensions, and startup survival strategies matter more than ever. managing directorkurtgielen https://insights.citeline.com/medtech-insight/conferences/lsi-panel-investors-medtech-leaders-expect-ma-rebound-in-2026-but-only-for-strong-assets-KZA5K5N4FNBABBQOYT2BAYYEX4/ LSI Panel: Investors, Medtech Leaders Expect M&A Rebound In 2026, But Only For Strong Assets Mar 26, 2026 - Medtech leaders expect dealmaking to rebound in 2026, but buyers are more selective. Buyers are focused on high-value assets, and AI must prove real clinical... medtech leaderslsipanelexpect https://www.lsiusasummit.com/ LSI USA ‘26 Emerging Medtech Summit | Partner with the Leaders in Medtech Join the LSI USA Summit to discover emerging medtech companies, explore investment opportunities, and connect with leading strategics and industry experts. emerging medtech summitlsiusa